Learn · Legality

Is iboga legal? Country by country

The answer depends on the country, the preparation and the activity. Possession, medical treatment and taking a plant across a border are different legal questions. Explore selected countries below, then read the details before making plans.

7-minute read · Updated September 2026 · Reviewed by the Bwiti Life medical team

Scroll to explore

Why the law is so uneven

Drug scheduling, medicine approval and permission to import are different legal questions. A country may expressly control ibogaine, regulate a preparation as a medicine, or have no published iboga-specific determination in the sources reviewed. The atlas separates these findings and links to the rules behind each profile. A missing classification is not evidence of permission.

Mexico

Ibogaine is not named in the controlled-substance lists in the General Health Law reviewed for this guide. This limited observation does not establish that every preparation, sale or treatment is authorized. Health-service, medicine and import requirements must be checked separately. Bwiti Life operates on the Mayan Riviera near Cancun, Mexico; our safety page explains the team and medical safeguards.

United States

Ibogaine is a Schedule I substance under federal law: no accepted medical use, illegal to possess, manufacture or distribute. Iboga root bark, as the source of ibogaine, falls under the same prohibition. Several states have moved toward research: Kentucky debated a large ibogaine research fund in 2023 and 2024, and Texas passed legislation in 2025 to fund ibogaine clinical trials. None of this changes possession law today. American guests travel to Mexico for the retreat and bring nothing back.

Canada

Health Canada added ibogaine to the Prescription Drug List in 2017. It is not a controlled substance, but it cannot be sold or provided without authorization, and no product is approved. In practice Canadians travel to Mexico or elsewhere.

United Kingdom

Ibogaine is not named in the Misuse of Drugs Act, but supplying it falls under the Psychoactive Substances Act 2016. Possession for personal use is not itself an offence under that act; importing or supplying is. Retreats are not available in the UK.

European Union

Rules differ across European jurisdictions. France’s 2007 narcotics order explicitly includes iboga plants, ibogaine and specified preparations. Do not infer another country’s position from France, or from the fact that a provider advertises there. Check possession, treatment, supply and import rules with the relevant national authority.

Czechia: in a 2025 response specifically about iboga, the Ministry of Health stated that neither the plant nor ibogaine appeared in the controlled-drug or listed-psychoactive-substance regulations it identified. The ministry did not resolve other criminal-law questions. This finding is not approval of a treatment, medicinal product or import. Select Czechia in the atlas for the medicines framework and sources.

Portugal: iboga and ibogaine are not named in the reviewed national drug tables, including the May 2026 amendments, or the current new psychoactive substance list. The atlas shows this named-list finding in green. The scope of derivative provisions and the permissions for a particular product or treatment remain separate questions.

Spain: ibogaine is not named in the reviewed psychotropic lists updated in April 2026 or national narcotic designations. Amber highlights the medicines rules for plant preparations presented for therapeutic use. Select Spain in the atlas for the treatment and import requirements.

South America: country by country

South America has no single iboga regime. Argentina expressly controls ibogaine; Brazil distinguishes drug scheduling from commercial-sale restrictions. Other profiles identify the national lists reviewed and any unresolved classification questions. Select a country for its rules on possession, treatment and borders.

All 12 countriesChoose a country to see its status and primary sources
French Guiana and South Atlantic territoriesThese jurisdictions have separate applicable laws

Asia and the Middle East

Asia has no single legal regime for iboga. The plant, isolated ibogaine, medical treatment and import can each be regulated differently. Use the regional directory below to open a country’s profile on the map, including the applicable rules and their sources.

Specific controls already documented: South Korea expressly names ibogaine in Annex 3 of its Narcotics Control Act Enforcement Decree. Taiwan lists it as a Schedule 2 controlled drug. Saudi Arabia’s September 2026 schedules name both ibogaine and the iboga plant. Israel’s 2015 enacted amendment names ibogaine in its Dangerous Drugs Ordinance.

Not explicitly scheduled in the lists reviewed: this narrower finding is supported for Japan, Macao and Vietnam. Their profiles link the underlying schedules and 2026 updates. Medicine approval, treatment and imports remain separate legal questions.

Mainland China: strict treatment and import controls. The map uses amber to highlight these requirements. The national catalog review did not identify an ibogaine entry or a general psychedelic-analogue rule covering it. That finding does not establish an authorized treatment route. The Drug Administration Law separately restricts clinical imports and prohibits importing drugs with uncertain therapeutic value or serious adverse reactions. The implementing regulation effective May 15, 2026 sets further clinical-import and personal-use conditions. Each preparation and analogue needs an individual assessment.

Restrictions can concern a specific product: Armenia, Kazakhstan and Kyrgyzstan apply the EAEU rule excluding all parts of iboga from food supplements. Tajikistan has an explicit iboga restriction in its food-safety regulation. These findings concern supplement ingredients; they do not establish the separate drug-law classification of possession or medical use.

For a blue country, the linked sources document a local framework but do not yet settle the specific iboga classification. The country is included; that legal question remains open. A retreat advertisement or a general medicine-import procedure cannot settle it.

East and North Asia9 countries and territories
Southeast Asia11 countries and territories
South Asia8 countries and territories
Central Asia5 countries and territories
West Asia and the Middle East19 countries and territories

Gabon and the rest of Africa

Gabon is central to the Bwiti tradition and is where our practitioners trained. Traditional use and export are separate matters: the 2019 export order covers all or part of iboga, raw or derived, and provides for exceptional special authorizations. It is not limited to wild plants. Verify applicable permissions and sourcing documentation. Other African countries have their own rules.

Costa Rica, Brazil, Australia, New Zealand

  • Costa Rica: the Ministry of Health’s 2025 warning describes unauthorized therapeutic use and registration requirements. The presence of a retreat does not establish permission.
  • Brazil: ANVISA states that ibogaine has not been evaluated for authorization and commercial sale is prohibited. This is distinct from a blanket criminal-possession classification.
  • New Zealand: listed as a prescription medicine; prescribing, product approval and import requirements are separate questions.
  • Australia: ibogaine appears in Schedule 4 of the June 2026 Poisons Standard. Prescription classification, product access and import conditions are separate requirements.

What it means if you travel for a retreat

A retreat’s location does not settle every legal question for a visitor. Check the rules that apply to your travel, your nationality and any import or export. Do not assume that a plant or medicine can cross a border because it is available at your destination. Bwiti Life gives nothing to take away, and asks you to leave with nothing. Your medical records, your notes and your integration calls travel with you; the plant stays in Mexico.

This page is a summary for information, updated in September 2026. It is not legal advice. Laws change, and enforcement differs from the text. Check your own jurisdiction.

Questions people ask

Is it legal for an American to attend an iboga retreat in Mexico?

A US scheduling rule does not itself establish the permissions for a service in Mexico. Verify the destination’s treatment and provider requirements and any rules relevant to your circumstances. US federal controls apply to ibogaine brought into the United States; attendance is not permission to import it.

Will a retreat show up on my record?

We handle personal information under our privacy policy. We cannot guarantee that a visit will have no record or that information can never be disclosed where the law requires it. Ask the team about confidentiality and consult a legal adviser for concerns specific to your circumstances.

Could ibogaine become legal in the United States?

The direction is toward research: state-funded trials in Texas, federal interest in psychedelic therapies, and a growing body of published results. Rescheduling would take years and clinical trials. Any research or other authorized access has its own conditions; federal scheduling and state initiatives must be considered separately.

Is iboga legal to grow?

Plant cultivation, possession of root bark and handling purified ibogaine can have different rules. Some jurisdictions explicitly list the plant; others regulate particular substances or activities. Check the actual plant and proposed activity with the local authority rather than assuming that a molecule’s classification settles cultivation law.